ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

February 13, 1976

Prevention Program Being Developed For Primary Providers

January 29, 1988

Two Groups Form to Mark Cancer Act’s 25th Anniversary

May 31, 1996

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012